Should You Buy Apple Stock Now?
Tech behemoth Apple Inc. (NASDAQ:AAPL) is not having a good…
Sell
33
SMMT Quote, Financials, Valuation and Earnings
Last price:
$20.61
Seasonality move
:
-4.4%
Day range:
$19.82 - $21.20
52-week range:
$6.78 - $36.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
15,670.26x
P/B ratio:
44.41x
Volume:
3.9M
Avg. volume:
5.5M
1-year change:
153.26%
Market cap:
$15.3B
Revenue:
--
EPS (TTM):
-$0.35
SMMT Analysts' Consensus Rating
The 7 analysts providing 12-month price projections for Summit Therapeutics shares anticipate an average target of $37.47, ranging from a low estimate of $29.95 to a high estimate of $43.97. This average target implies a growth of 82% compared to the current stock price of $20.59.
Consensus Price Target
$37.47
Highest Price Target
$43.97
Lowest Price Target
$29.95
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 3 | 7 | 7 |
| Hold | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
SMMT Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will HBM Stock Be in 5 Years?
Hudbay Minerals (NYSE:HBM) is a Canadian mining company with a…
Should You Buy Visa Stock Now?
Having operations across 200 countries, Visa Inc. (NYSE:V) is arguably…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 48x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 34x
Alerts
Sell
19
LULU alert for Jun 7
Lululemon Athletica [LULU] is down 19.83% over the past day.
Sell
46
DOCU alert for Jun 7
Docusign [DOCU] is down 18.99% over the past day.
Buy
66
BYRN alert for Jun 7
Byrna Technologies [BYRN] is up 18.03% over the past day.
